Ignite Creation Date:
2025-12-24 @ 11:54 PM
Ignite Modification Date:
2025-12-25 @ 9:50 PM
Study NCT ID:
NCT00165451
Status:
COMPLETED
Last Update Posted:
2011-07-07
First Post:
2005-09-09
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2001-06
Start Date Type:
None
Primary Completion Date:
2006-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-10
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-09
First Submit QC Date:
None
Study First Post Date:
2005-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2011-07-06
Last Update Post Date:
2011-07-07
Last Update Post Date Type:
ESTIMATED